Antimitotic chemotherapy
Lyon Medical 224(42): 869-896
1970
ISSN/ISBN: 0024-7790 PMID: 5502913 Document Number: 28352
Document emailed within 1 workday
Related Documents
Compton, D.A. 1999: New tools for the antimitotic toolbox Science 286(5441): 913-914Delatour, P.; Richard, Y. 1976: The embryotoxic and antimitotic properties of a series of benzimidazoles Therapie 31(4): 505-515
Broda, B.; Grabias, B.; Mikołajewska, H. 1983: Determination of antimitotic activity in new 1-methylpiperazine and perhydroazepine derivatives Acta Poloniae Pharmaceutica 40(4): 489-495
Bassleer, R.; Goessens, G.; Chèvremont, M. 1986: Effect of antimitotic agents on normal or cancerous animal cells Revue Medicale de Liege 41(20): 816-822
Ershova, I.A.; Minakova, S.M.; Nasybullin, R.A.; Chernov, V.A. 1974: Antineoplastic and antimitotic effect of prospidin in hypophysectomized and thyroidectomized rats with sarcoma 45 Farmakologiia i Toksikologiia 37(6): 715-717
Chłopkiewicz, B.; Anuszewska, E. 1989: Comparison of transforming, antimitotic and chromosomal aberration-inducing properties of melphalan and cyclophosphamide Polish Journal of Pharmacology and Pharmacy 41(4): 293-298
Brulfert, A.; Lévy, F.; Deysson, G. 1976: Study on a synchronized population of the antimitotic effect of cycloheximide at various phases of the cell cycle in Allium sativum L Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 170(1): 9-13
Laccourreye, H.; Haguet, J.F.; Prat, C.; Aboudarham, J.F. 1974: 2-year computerized statistical study of the efficacy of supplementary antimitotic treatment of cancers of the larynx and pharynx Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 91(12): 641-656
Uryvaeva, I.V.; Sokolova, A.S.; Faktor, V.M.; Chernov, V.A.; Brodsky WYa 1983: An anticancer drug prospidine: failure to reveal antimitotic and clastogenic action on regenerating mouse liver Neoplasma 30(4): 457-462
Kostyuchenko, N.; Pushkarev, V.; Kashevarov, G.; Tronko, M.; Komisarenko, I.; Mikosha, O. 2005: Effects of N-acylethanolamines and various antimitotic agents on apoptotic DNA fragmentation in conventionally normal and tumor tissue of human adrenals Experimental Oncology 27(3): 215-219
Semont, H.; Hecquet, C.; Adolphe, M.; Deysson, G. 1981: Effect of three alkylating antimitotic agents and their metabolites on in vitro monogranulocytic colony forming cells from mouse bone marrow Arzneimittel-Forschung 31(3): 470-473
Bournique, C.P.; Chottard, J.C.; Deysson, G. 1975: Antimitotic properties of platinum (II) complexes of the type trans PtC12 (olefin) (pyridine). Study by means of the Allium test Annales Pharmaceutiques Francaises 33(2): 77-84
Tew, K.D.; Woodworth, A.; Stearns, M.E. 1986: Relationship of glutathione depletion and inhibition of glutathione-S-transferase activity to the antimitotic properties of estramustine Cancer Treatment Reports 70(6): 715-720
Deysson, G.; Adolphe, M.; Semont, H. 1981: Comparison of the antimitotic properties of cyclophosphamide and its biotransformation products on meristema plant cells and animal cells in in vitro culture Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 175(2): 182-186
Sasaki, Y.; Mochizuki, K.; Shigeto, E.; Konishiike, J. 1986: Present status and chemotherapy of extrapulmonary tuberculosis in national sanatoria--urinary tuberculosis. Report of the B series of 26th Controlled Trials of Chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS) Kekkaku: 61(1): 9-13
Căinap, C.; Părău, A.; Muntean, A.; Hodorog, A.; Vlad, L. 2010: New generation chemotherapy in the treatment of operated gastric cancer--an alternative to traditional chemotherapy Chirurgia 105(1): 31-36
Pavlovsky, S.; Maschio, M.; Santarelli, M.T.; Muriel, F.S.; Corrado, C.; Garcia, I.; Schwartz, L.; Montero, C.; Sanahuja, F.L.; Magnasco, O. 1988: Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease Journal of the National Cancer Institute 80(18): 1466-1473
Sternberg, C.N.; Yagoda, A.; Scher, H.I.; Whitmore, W.F.; Herr, H.W.; Morse, M.J.; Sogani, P.C.; Bosl, G.; Watson, R.C.; Hollander, P.S. 1988: Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy Progress in Clinical and Biological Research 260: 551-555
Todoroki, T. 2000: Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery Hepato-Gastroenterology 47(33): 644-649
Sato, A.; Yamamoto, W.; Takebuchi, K.; Hiratsuka, N.; Tadokoro, K.; Ushio, J. 2001: Home chemotherapy and/or outpatient chemotherapy for patient with advanced gastric cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 616-620